2021-01-06,"Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazias Paxalisib and Kintaras VAL-083 in GBM AGILE Trial"
2021-01-05,Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
2020-12-03,Kintara Therapeutics to Present at the 2nd Annual Glioblastoma Drug Development Summit
2020-12-01,KTRA: Year-End Kick-off for GCAR Trial
2020-11-30,KTRA: VAL-083 Poster Updates
2020-11-19,Kintara Therapeutics Reports 10 Months Progression-Free Survival in Newly-Diagnosed MGMT-unmethylated GBM from Ongoing MD Anderson Cancer Center Phase 2 Study
2020-11-13,Kintara Therapeutics Announces First Fiscal Quarter 2021 Financial Results and Recent Corporate Updates
2020-10-21,Kintara and the Global Coalition for Adaptive Research Execute Agreement for VAL-083's Participation in the GBM AGILE Registrational Study
2020-10-12,KTRA: Merger Complete
2020-10-01,3 Strong Buy Healthcare Stocks Under $5 That Could Go Boom
2020-09-21,Kintara Therapeutics Announces Fiscal Year 2020 Financial Results and Recent Corporate Updates
2020-09-16,KTRA: Two Phase III Ready Assets
2020-09-01,Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million
2020-08-31,LD Micro - 360 Companies - Set to Present this Week
2020-08-26,"Kintara Therapeutics (formerly DelMar Pharmaceuticals) to Present at the LD Micro 500 Virtual Conference on September 3rd, 2020"
2020-08-25,Kintara Therapeutics Announces Closing of Additional $2.2 Million Private Placement Priced at the Market
2020-08-21,Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market
2020-08-21,Kintara Therapeutics (formerly DelMar Pharmaceuticals) Regains Compliance with NASDAQ Minimum Bid Price Requirement
